GRCE Grace Therapeutics Inc.

  1. Stocks
  2. Healthcare
  3. NASDAQ: GRCE

Price (delayed)

$2.12

Market cap

$44.6M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.17

Enterprise value

$30.84M

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 2
Highlights
Grace Therapeutics's quick ratio has increased by 39% QoQ and by 27% YoY
Grace Therapeutics's net income has plunged by 159% from the previous quarter and by 96% YoY
The EPS has dropped by 149% since the previous quarter and by 52% year-on-year
Sector: Healthcare
Industry: Biotechnology
Website: http://www.acastipharma.com
Peers: OPK ORGO

Key stats

What are the main financial stats of GRCE

GRCE stock price

How has the Grace Therapeutics stock price performed over time
Intraday
-0.93%
1 week
-0.93%
1 month
-3.64%
1 year
-31.83%
YTD
-38.73%
QTD
-6.61%

Financial performance

How have Grace Therapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$23.91M
Net income
-$20.22M
Gross margin
N/A
Net margin
N/A
Grace Therapeutics's net income has plunged by 159% from the previous quarter and by 96% YoY
GRCE's operating income has dropped by 116% since the previous quarter and by 61% year-on-year

Price vs fundamentals

How does GRCE's price correlate with its fundamentals

Growth

What is Grace Therapeutics's growth rate over time

Valuation

What is Grace Therapeutics stock price valuation
P/E
N/A
P/B
0.72
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has dropped by 149% since the previous quarter and by 52% year-on-year
The stock's P/B is 44% above its 5-year quarterly average of 0.5 but 10% below its last 4 quarters average of 0.8
The company's equity fell by 25% QoQ and by 24% YoY

Efficiency

How efficient is Grace Therapeutics business performance
The ROA has plunged by 179% from the previous quarter and by 108% YoY
The ROE has plunged by 176% from the previous quarter and by 95% YoY

Dividends

What is GRCE's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for GRCE.

Financial health

How did Grace Therapeutics financials performed over time
The total liabilities has plunged by 70% YoY and by 32% from the previous quarter
The company's current ratio rose by 42% QoQ and by 29% YoY
The debt is 100% lower than the equity
The company's equity fell by 25% QoQ and by 24% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.